Search

everythinglearnresearchcommunity

for

Search:↓

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Natural products can help overcome cancer drug resistance.

Physical activity, height, and smoking affect prostate cancer risk.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

A group has developed therapies that show promise for treating cancer and various other conditions.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Skin problems are common in thyroid disorders, with dry skin in hypothyroidism and warm, soft skin in hyperthyroidism.

Superoxide dismutases help balance cell stress and may aid cancer treatment.

Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.